NCT07266662Recruiting
Comparative Effects of Sensory Augmentation and Neuromodulation on Enhancing Motor Recovery Among Stroke Survivors
Source: ClinicalTrials.gov · Last updated 17 Dec 2025
Brief summary (registry, in English)
This study aims to evaluate the effectiveness of two rehabilitation techniques-Sensory Augmentation (using mirror therapy) and Neuromodulation (using transcranial direct current stimulation, tDCS)-in improving motor recovery among stroke survivors. Stroke often results in long-term impairments, particularly in upper limb motor function, which is critical for daily activities. Although current rehabilitation strategies help, more effective solutions are needed to enhance recovery. Participants, aged 45-65 with chronic stroke and upper extremity impairments, will be randomized into three groups: Group 1 will receive a combination of sensory augmentation (mirror therapy) and neuromodulation (tDCS) with routine physical therapy; Group 2 will receive sensory augmentation (mirror therapy) with routine physical therapy; and Group 3 will receive neuromodulation (tDCS) with routine physical therapy. The interventions will take place four times a week for 8 weeks, and participants will undergo motor function assessments, including the Fugl-Meyer Assessment and Jebsen-Taylor Test, before and after the intervention. The study will compare the effects of each intervention on motor recovery, specifically focusing on upper limb function and motor control. The findings could lead to improved rehabilitation protocols, offering stroke survivors better therapeutic options and enhancing their quality of life.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 36 (estimated)
- First submitted
- 24 Nov 2025
- Start date
- 25 Nov 2025
- Primary completion date
- 25 May 2026
- Lead sponsor
- Lahore University of Biological and Applied Sciences
- Diseases
- Stroke
- NCT number
- NCT07266662
What you commit to
- Study type: Interventional
- Planned participants: 36
- From 25 Nov 2025 to the primary completion date, 25 May 2026
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Serious systemic impairment or concomitant diseases
Other illness
- Serious cognitive impairment,
- Orthopedic disease
- Neurological conditions (other than stroke)
- Recurrence of stroke or epilepsy during the study period
Other
- Vestibular Dysfunction
- Severe vision or visuospatial neglect
- Spasticity (Modified Ashworth scale \>3)
- Upper extremity contractures
- Upper extremity fractures
- Patients refused to participate in the experiment
Who the study is looking for
- Age: 45-65
- Gender: both male and female
- Ischemic stroke
- Diagnosed cases of middle cerebral artery stroke by neurologist
- Stage of recovery - Chronic (more than 6 months)
- Burnstromm recovery stage 3
- Good Compliance
Age in the registry: 45 years to 56 years · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Pakistan Society of Rehabilitation and Differently Abled Hospital Coordinator of this site? Confirm its status | Lahore | Pakistan | Recruiting |
| Lahore University of Biological and Applied Sciences Coordinator of this site? Confirm its status | Lahore | Pakistan | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.